NO20031999D0 - Ikke begrensede somatiske stamceller derivert fra humant navlestrengblod - Google Patents

Ikke begrensede somatiske stamceller derivert fra humant navlestrengblod

Info

Publication number
NO20031999D0
NO20031999D0 NO20031999A NO20031999A NO20031999D0 NO 20031999 D0 NO20031999 D0 NO 20031999D0 NO 20031999 A NO20031999 A NO 20031999A NO 20031999 A NO20031999 A NO 20031999A NO 20031999 D0 NO20031999 D0 NO 20031999D0
Authority
NO
Norway
Prior art keywords
stem cells
well
cord blood
somatic stem
restricted
Prior art date
Application number
NO20031999A
Other languages
English (en)
Other versions
NO20031999L (no
Inventor
Peter Wernet
Original Assignee
Kourion Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kourion Therapeutics Gmbh filed Critical Kourion Therapeutics Gmbh
Publication of NO20031999D0 publication Critical patent/NO20031999D0/no
Publication of NO20031999L publication Critical patent/NO20031999L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
NO20031999A 2000-11-03 2003-05-02 Ikke-begrensede somatiske stamceller avledet fra humant navlestrengblod NO20031999L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24516800P 2000-11-03 2000-11-03
PCT/EP2001/012768 WO2002036751A2 (en) 2000-11-03 2001-11-03 Human cord blood derived unrestricted somatic stem cells (ussc)

Publications (2)

Publication Number Publication Date
NO20031999D0 true NO20031999D0 (no) 2003-05-02
NO20031999L NO20031999L (no) 2003-07-02

Family

ID=22925565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031999A NO20031999L (no) 2000-11-03 2003-05-02 Ikke-begrensede somatiske stamceller avledet fra humant navlestrengblod

Country Status (25)

Country Link
US (3) US7560280B2 (no)
EP (1) EP1404815B1 (no)
JP (2) JP4799804B2 (no)
CN (1) CN100480375C (no)
AT (1) ATE340255T1 (no)
AU (2) AU2953302A (no)
BG (1) BG107770A (no)
CA (1) CA2426987C (no)
CY (1) CY1106287T1 (no)
CZ (1) CZ20031165A3 (no)
DE (1) DE60123293T2 (no)
DK (1) DK1404815T3 (no)
EA (1) EA008619B1 (no)
EE (1) EE200300205A (no)
ES (1) ES2272563T3 (no)
HK (1) HK1071771A1 (no)
HU (1) HUP0301600A3 (no)
IL (2) IL155608A0 (no)
MX (1) MXPA03003844A (no)
NO (1) NO20031999L (no)
PL (1) PL362293A1 (no)
PT (1) PT1404815E (no)
SK (1) SK5242003A3 (no)
UA (1) UA81390C2 (no)
WO (1) WO2002036751A2 (no)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338928A1 (en) * 1998-07-30 2000-02-10 Hynda K. Kleinman Thymosin .beta.4 promotes wound repair
US8075881B2 (en) 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
US8252280B1 (en) 1999-08-05 2012-08-28 Regents Of The University Of Minnesota MAPC generation of muscle
US7015037B1 (en) * 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
EP2348104A1 (en) * 1999-08-05 2011-07-27 Mcl Llc Multipotent adult stem cells and methods for isolation
US7927587B2 (en) * 1999-08-05 2011-04-19 Regents Of The University Of Minnesota MAPC administration for the treatment of lysosomal storage disorders
US8609412B2 (en) * 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
US10638734B2 (en) 2004-01-05 2020-05-05 Abt Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
EP1367899A4 (en) 2001-02-14 2004-07-28 Leo T Furcht TOTIPOTENT ADULT STEM CELLS, SOURCES OF SUCH CELLS, METHODS FOR OBTAINING AND MAINTAINING SAME, METHODS FOR DIFFERENTIATING THESE CELLS, METHODS OF USING SAME, AND CELLS DERIVED FROM THE ABOVE-MENTIONED CELLS
CN101549148A (zh) * 2001-08-29 2009-10-07 雷根内克斯生物制药有限公司 多肽在制备用于促进心内膜细胞向间质细胞转化的药物中的应用
DE10144326B4 (de) * 2001-09-10 2005-09-22 Siemens Ag Verfahren und System zur Überwachung eines Reifenluftdrucks
DE10158680B4 (de) * 2001-11-30 2004-04-08 Universitätsklinikum Hamburg-Eppendorf Verfahren zur ex vivo-Expansion und -Differenzierung von multipotenten Stammzellen
KR20040075957A (ko) * 2002-01-23 2004-08-30 유니버시티 오브 유타 리서치 파운데이션 별아교세포 제한 전구체 세포의 순수한 집단과 그것을분리하고 이용하는 방법
CN1281739C (zh) * 2002-02-19 2006-10-25 美迪宝斯特有限公司 从脐带血中分离并扩大培养间充质干细胞/祖细胞及将脐带血来源的间充质干细胞/祖细胞分化成各种间充质组织的方法
KR101042448B1 (ko) 2002-11-26 2011-06-16 안트로제네시스 코포레이션 세포요법제, 세포요법제 단위 및 이를 이용한 치료방법
AU2003298016A1 (en) 2002-11-27 2004-06-23 Regents Of The University Of Minnesota Homologous recombination in multipotent adult progenitor cells
US7470538B2 (en) * 2002-12-05 2008-12-30 Case Western Reserve University Cell-based therapies for ischemia
EP1583422B1 (en) * 2002-12-05 2016-03-30 Case Western Reserve University Cell-based therapies for ischemia
JP3762975B2 (ja) * 2003-03-18 2006-04-05 学校法人慶應義塾 単球由来多能性細胞ｍｏｍｃ
US20040203142A1 (en) * 2003-04-14 2004-10-14 Reliance Life Sciences Pvt. Ltd. Growth of neural precursor cells using umbilical cord blood serum and a process for the preparation thereof for therapeutic purposes
CA2530533C (en) 2003-06-27 2015-02-10 Ethicon, Incorporated Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
CA2529718C (en) 2003-06-27 2012-10-23 Universite Laval Method of isolating cells from umbilical cord
DE602004031033D1 (de) * 2003-10-09 2011-02-24 Core Dynamics Ltd Verfahren zum tiefgefrieren, auftauen und transplantieren von lebensfähigem knorpel
EP1694345A1 (en) 2003-12-04 2006-08-30 Regents Of The University Of Minnesota Compositions and methods for the treatment of lysosomal storage disorders
GB0329449D0 (en) * 2003-12-19 2004-01-28 Omnicyte Ltd Stem cells
CA2550326A1 (en) * 2003-12-19 2005-07-14 Viacell, Inc. Use of human cord blood-derived pluripotent cells for the treatment of disease
EP1544290A1 (en) * 2003-12-19 2005-06-22 Yu-Show Fu A cell system for generating somatic cells
US7935478B2 (en) * 2004-02-02 2011-05-03 Core Dynamics Limited Biological material and methods and solutions for preservation thereof
WO2005072790A1 (en) * 2004-02-02 2005-08-11 I.M.T. Interface Multigrad Technology Ltd. Device for directional cooling of biological matter
JP2007521831A (ja) 2004-02-11 2007-08-09 アルダジェン， インコーポレイテッド 幹細胞集団および使用方法
US7670596B2 (en) 2004-04-23 2010-03-02 Bioe, Inc. Multi-lineage progenitor cells
US7622108B2 (en) 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
US20070298015A1 (en) * 2004-04-28 2007-12-27 Viacell, Inc. Treatment of Muscular Dystrophy with Mobilized Peripheral Blood Pluripotent Cells
EP1756267A2 (en) 2004-05-14 2007-02-28 Becton, Dickinson and Company Stem cell populations and methods of use
JP5096148B2 (ja) * 2004-06-07 2012-12-12 コア・ダイナミクス・リミテッド 生物学的試料の殺菌方法
WO2006016372A1 (en) * 2004-08-12 2006-02-16 I.M.T. Interface Multigrad Technology Ltd. Method and apparatus for freezing or thawing of a biological material
AU2006203990B2 (en) 2005-01-07 2011-08-11 Wake Forest University Health Sciences Regeneration of pancreatic islets by amniotic fluid stem cell therapy
EP2428563A1 (en) * 2005-02-10 2012-03-14 Regents Of The University Of Minnesota Vascular/lymphatic endothelial cells
WO2006090372A2 (en) * 2005-02-22 2006-08-31 I.M.T. Interface Multigrad Technology Ltd. Preserved viable cartilage, method for its preservation, and system and devices used therefor
CN101575590B (zh) * 2005-02-28 2012-05-23 中国医学科学院血液学研究所泰达生命科学技术研究中心 人脐带间充质干细胞的制备方法
EP1874922A4 (en) * 2005-04-19 2009-10-28 Univ Johns Hopkins METHOD USING STROMA CELLS FROM UMBILICAL CORD BLOOD TO DEVELOP AND GRAFT NUCLEAR CELLS DERIVED FROM UMBILICAL CORD BLOOD
CN101218341A (zh) * 2005-05-05 2008-07-09 明尼苏达大学董事会 Nk细胞抑制作用用于促进定植的mhc-i阴性细胞持续存在的用途
AU2005331534B2 (en) * 2005-05-05 2011-12-08 Regents Of The University Of Minnesota Use of MAPC or progeny therefrom to populate lymphohematopoietic tissues
EP1888741B1 (en) * 2005-05-27 2013-04-17 Viacell, Inc. Treatment of ischemia using stem cells
WO2007117262A2 (en) * 2005-07-29 2007-10-18 Athersys, Inc. Culture of non-embryonic cells at high cell density
US8198085B2 (en) * 2005-08-03 2012-06-12 Core Dynamics Limited Somatic cells for use in cell therapy
DE602005017812D1 (de) * 2005-08-26 2009-12-31 Seoul Nat Univ Ind Foundation Multipotente blutstammzellen aus der nabelschnur und zellbehandlungsmittel damit zur behandlung der ischämischen krankheit
EP1941032A2 (en) 2005-10-14 2008-07-09 Regents Of The University Of Minnesota Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
US9175261B2 (en) 2005-12-16 2015-11-03 DePuy Synthes Products, Inc. Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
JP5550235B2 (ja) 2005-12-29 2014-07-16 アントフロゲネシス コーポレーション 胎盤幹細胞集団
EP2019858B1 (en) * 2006-04-17 2012-06-13 BioE LLC Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
US7875453B2 (en) * 2006-06-14 2011-01-25 Bioe Llc Differentiation of multi-lineage progenitor cells to hepatocytes
JP5670053B2 (ja) 2006-11-13 2015-02-18 エシコン・インコーポレイテッドＥｔｈｉｃｏｎ， Ｉｎｃｏｒｐｏｒａｔｅｄ マイクロキャリアを使用した、産褥由来の細胞の生体外での拡大
WO2008085229A2 (en) * 2006-11-15 2008-07-17 Arteriocyte Inc. Cell-based therapies for treating liver disease
US9005964B2 (en) * 2006-11-24 2015-04-14 Regents Of The University Of Minnesota Endodermal progenitor cells
EP2099901B1 (en) * 2006-11-30 2015-09-09 Medipost, Co., Ltd. Use of a composition contaning human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells
CN101835479A (zh) * 2007-07-25 2010-09-15 佰欧益有限公司 多系祖细胞分化为软骨细胞
EP2212418A4 (en) * 2007-10-31 2010-12-08 Cryo Cell Int METHOD FOR THE CO-CULTIVATION OF CELLS FROM CORD BLOOD AND MENSTRUELLEN STEM CELLS
WO2009085216A2 (en) 2007-12-20 2009-07-09 Squicor Compositions and methods for detecting or elimninating senescent cells to diagnose or treat disease
AU2009205886B2 (en) * 2008-01-18 2015-08-27 Katholieke Universiteit Leuven Stem cell aggregates and methods for making and using
US20090202978A1 (en) * 2008-02-13 2009-08-13 Ginadi Shaham Method and apparatus for freezing of a biological material
US20090233993A1 (en) * 2008-03-06 2009-09-17 Burnham Institute For Medical Research Compositions and methods for inhibiting gsk3 activity and uses thereof
CN101543644B (zh) * 2008-03-27 2012-07-25 中国人民解放军总医院 无支架工程软骨组织的构建方法及其产品
WO2009143241A2 (en) * 2008-05-21 2009-11-26 Bioe, Inc. Differentiation of multi-lineage progenitor cells to pancreatic cells
MX2011001992A (es) 2008-08-22 2011-03-29 Anthrogenesis Corp Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias.
US8822647B2 (en) 2008-08-26 2014-09-02 City Of Hope Method and compositions using a chimeric antigen receptor for enhanced anti-tumor effector functioning of T cells
GB0818725D0 (en) 2008-10-13 2008-11-19 Habib Nagy A Pharmaceutical composition
EP2182055A1 (en) 2008-10-14 2010-05-05 Heinrich-Heine-Universität Düsseldorf Human cord blood derived unrestricted somatic stem cells (USSC)
EP2362899A1 (en) 2008-10-31 2011-09-07 Katholieke Universiteit Leuven Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells
KR20100054711A (ko) 2008-11-14 2010-05-25 메디포스트(주) 간엽 줄기세포 또는 이의 배양액을 포함하는 신경질환의 예방 또는 치료용 조성물
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
US20110020292A1 (en) * 2009-07-21 2011-01-27 Abt Holding Company Use of Stem Cells to Reduce Leukocyte Extravasation
CA2768576C (en) * 2009-07-21 2022-12-06 Abt Holding Company Use of stem cells to reduce leukocyte extravasation
WO2011069093A1 (en) 2009-12-04 2011-06-09 Boston Biomedical Research Institute, Inc. Detecting and counting tissue-specific stem cells and uses thereof
US8759098B2 (en) 2009-12-04 2014-06-24 Boston Biomedical Research Institute, Inc. Method for cloning pluripotent stem cells
SG10201907877YA (en) 2010-02-25 2019-09-27 Abt Holding Co Modulation of macrophage activation
WO2011106476A1 (en) * 2010-02-25 2011-09-01 Abt Holding Company Modulation of microglia activation
US20110206647A1 (en) * 2010-02-25 2011-08-25 Abt Holding Company Modulation of Angiogenesis
EP2555783A1 (en) 2010-04-08 2013-02-13 Anthrogenesis Corporation Treatment of sarcoidosis using placental stem cells
SG10201503700WA (en) 2010-05-12 2015-06-29 Abt Holding Co Modulation of splenocytes in cell therapy
WO2011158125A2 (en) 2010-06-17 2011-12-22 Katholieke Universiteit Leuven Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
US9057734B2 (en) 2010-08-23 2015-06-16 President And Fellows Of Harvard College Optogenetic probes for measuring membrane potential
CN103237886B (zh) 2010-08-24 2018-10-30 明尼苏达大学董事会 细胞集合体的非静态悬浮培养
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
EP2697360A1 (en) * 2011-04-11 2014-02-19 Jaffar Ali Bin M. Abdullah Protein-free culture media products
CN102776150A (zh) * 2011-05-13 2012-11-14 上海交通大学医学院附属第九人民医院 一种诱导脐带间充质干细胞分化为内皮细胞的方法
ES2707579T3 (es) 2011-06-01 2019-04-04 Celularity Inc Tratamiento del dolor usando citoblastos placentarios
ES2763331T3 (es) 2011-06-06 2020-05-28 ReGenesys BVBA Expansión de células madre en biorreactores de fibra hueca
GB201119335D0 (en) 2011-11-09 2011-12-21 Univ Leuven Kath Hepatitis virus infectable stem cells
AU2014250761B2 (en) 2013-04-12 2019-02-28 Robert J. Deans Improving organs for transplantation
DK2992088T3 (da) 2013-04-30 2019-11-11 Univ Leuven Kath Celleterapi for myelodysplastiske syndromer
CN105992816B (zh) 2013-11-16 2018-04-17 泰尔茂比司特公司 生物反应器中的细胞扩增
EP2952578A1 (de) 2014-06-03 2015-12-09 Peter Wernet Epigenetische Reprogrammierung von fötalen Stammzellen
BR112017005631A2 (pt) 2014-09-19 2018-06-26 City Of Hope células t com receptor de antígeno coestimulador quimérico direcionadas à il13ra2
TW201613622A (en) * 2014-10-14 2016-04-16 Bionet Corp Composition for skincare and pharmaceutical composition and preparation method thereof
KR20180102661A (ko) 2016-01-21 2018-09-17 에이비티 홀딩 컴퍼니 상처 치유를 위한 줄기 세포
CN106377547B (zh) * 2016-09-30 2019-05-31 孔五一 脐带血再生粒子的提取方法及其用途
CN113637633B (zh) * 2021-08-16 2023-11-03 浙江大学 一种促进间充质干细胞向成骨细胞分化的方法
CA3232099A1 (en) 2021-09-23 2023-03-30 Adam Ezra Cohen Genetically encoded voltage indicators and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3639949A1 (de) * 1986-11-22 1988-06-09 Diagen Inst Molekularbio Verfahren zur trennung von langkettigen nukleinsaeuren
US5192553A (en) * 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5851832A (en) * 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
US5672346A (en) * 1992-07-27 1997-09-30 Indiana University Foundation Human stem cell compositions and methods
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
US5842477A (en) * 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
AU2730497A (en) * 1996-04-17 1997-11-07 Case Western Reserve University Cryopreservation and extensive subculturing of human mesenchymal stem cells
US5843633A (en) * 1996-04-26 1998-12-01 Amcell Corporation Characterization of a human hematopoietic progenitor cell antigen
JPH10295369A (ja) 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
JPH10306027A (ja) 1997-03-07 1998-11-17 Otsuka Pharmaceut Co Ltd 免疫寛容誘導剤
CA2296704C (en) * 1997-07-14 2010-10-19 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
DE19833476B4 (de) 1998-07-24 2005-08-25 Huss, Ralf, Dr. Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie
AU780365B2 (en) 1999-04-27 2005-03-17 Layton Bioscience, Inc. Cell therapy for chronic stroke
US20020142457A1 (en) * 1999-12-28 2002-10-03 Akihiro Umezawa Cell having the potentiality of differentiation into cardiomyocytes
CN1281739C (zh) * 2002-02-19 2006-10-25 美迪宝斯特有限公司 从脐带血中分离并扩大培养间充质干细胞/祖细胞及将脐带血来源的间充质干细胞/祖细胞分化成各种间充质组织的方法
US20040197310A1 (en) * 2003-02-12 2004-10-07 Sanberg Paul R. Compositions and methods for using umbilical cord progenitor cells in the treatment of myocardial infarction

Also Published As

Publication number Publication date
CN1553951A (zh) 2004-12-08
CA2426987C (en) 2013-06-11
JP2008179642A (ja) 2008-08-07
US7560280B2 (en) 2009-07-14
US7556801B2 (en) 2009-07-07
BG107770A (bg) 2004-02-27
AU2002229533B2 (en) 2007-07-26
HUP0301600A3 (en) 2005-12-28
EA008619B1 (ru) 2007-06-29
EE200300205A (xx) 2003-08-15
CN100480375C (zh) 2009-04-22
AU2953302A (en) 2002-05-15
US20050142118A1 (en) 2005-06-30
DK1404815T3 (da) 2007-01-08
CZ20031165A3 (cs) 2003-10-15
WO2002036751A2 (en) 2002-05-10
PL362293A1 (en) 2004-10-18
EP1404815B1 (en) 2006-09-20
HUP0301600A2 (hu) 2003-10-28
ES2272563T3 (es) 2007-05-01
MXPA03003844A (es) 2004-10-15
JP2004521617A (ja) 2004-07-22
WO2002036751A3 (en) 2004-01-08
ATE340255T1 (de) 2006-10-15
IL155608A (en) 2009-08-03
SK5242003A3 (en) 2003-11-04
DE60123293T2 (de) 2007-05-10
PT1404815E (pt) 2006-12-29
US20020164794A1 (en) 2002-11-07
IL155608A0 (en) 2003-11-23
NO20031999L (no) 2003-07-02
JP4805960B2 (ja) 2011-11-02
HK1071771A1 (en) 2005-07-29
US20090238803A1 (en) 2009-09-24
UA81390C2 (en) 2008-01-10
CA2426987A1 (en) 2002-05-10
EA200300536A1 (ru) 2003-12-25
JP4799804B2 (ja) 2011-10-26
DE60123293D1 (de) 2006-11-02
EP1404815A2 (en) 2004-04-07
CY1106287T1 (el) 2011-10-12

Similar Documents

Publication Publication Date Title
NO20031999D0 (no) Ikke begrensede somatiske stamceller derivert fra humant navlestrengblod
TW200516149A (en) Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
HUP0500477A2 (hu) Eljárások és készítmények embrionális és felnőttkori őssejtek támogatására stromasejtek alkalmazásával
BRPI0411856A (pt) composições e métodos para o aumento da atividade de telomerase
CY1111727T1 (el) Βλαστοκυτταρα, τα οποια λαμβανονται απο πολφο νεογιλων ή μονιμων οδοντων και οδοντικους βλαστους, ικανα να παραγουν ανθρωπινο οστικο ιστο
AU8180001A (en) Human growth hormone to stimulate mobilization of pluripotent hematopoietic stemcells
US20100172951A1 (en) Enhanced Medical Implant
Singh et al. Bone marrow derived stem cells in trauma and orthopaedics: a review of the current trend
DK1405906T3 (da) Schwann-celler stammende fra stromale knoglemarvsceller
Da Silva et al. Photobiomodulation: an effective approach to enhance proliferation and differentiation of adipose-derived stem cells into osteoblasts
Chen et al. Progress of periosteal osteogenesis: The prospect of in vivo bioreactor
Yankovskyi et al. Innovation technologies for human microbiome improvement
Sheikhani-Shahin et al. The healing effect of bone marrow-derived stem cells and aquatic activity in Achilles tendon injury
CN106563160A (zh) 制备组织工程骨的方法
McCall et al. Journal of Stem Cell Research
Hemalatha et al. Dental stem cells origin, banking, engineering and applications
Zou Tissue Engineering for Degenerative Intervertebral Discs
Madan et al. Stem Cells–A Scope For Regenerative Medicine
Sobajima et al. Adipose-derived stem cells: Use in clinical medicine
Mas-Bargues et al. Influence of partial O2 pressure on the adhesion, proliferation, and osteogenic differentiation of human dental pulp stem cells on β-tricalcium phosphate scaffold
Peng et al. Influence of various volume fractions of platelet-rich plasma on the proliferation of rat hair follicle stem cells
Choi et al. Human Bone Marrow-derived Mesenchymal Stem Cell could Differentiate into Ligament Fibroblast under Mechanical Strain
SHEIKHANI-SHAHIN Copyright© 2019 H. SHEIKHANI-SHAHIN, D. MEHRABANI, MJ ASHRAF, H. RAJABI, M. NOROUZIAN, F. RAHMANIFAR, S. DEHGHANI NAZHVANI, S. ZARE
Fraticelli Stem Cell Therapy Applications: The Challenge of Regenerative Medicine
ATE377427T1 (de) Verwendung des hepatozyten-wachstumsfaktors zur förderung der induktion der vaskulären differenzierung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application